Presentations
Jongh J.d., Post T., Freijer J., Winter W.d., Danhof M. and Ploeger B., Disease system analysis distinguishing disease status from disease process. Noordwijkerhout.(2006).
Post T.M., Winter W.d., Jongh J.d., Moules I., Urquhart R., Eckland D. and Danhof M., Treatment Efficacy of Combination-Therapy based on a Mechanistic Characterisation of Disease Processes in Type 2 Diabetes Mellitus over a two-year period. PAGE.(2005). [Link to publication]
Freijer J., Greef I.d., Post T. and Ploeger B., Robust fitting of pharmacokinetic models to Phase II/III clinical trial data. PAGE.(2005). [Link to publication]
Winter W.d., Jongh J.d., Urquhart R., Moules I., Eckland D. and Danhof M., Mechanistic Disease Progression Analysis Indicates that Pioglitazone Improves ß-cell Function in Treatment-naïve Type 2 Diabetics. ADA.(2005).
Post T., Winter W.d., Jongh J.d., Urquhart R., Moules I., Eckland D. and Danhof M., Treatment efficacy of Pioglitazone in Combination Therapy on Disease Progression in Type 2 Diabetes Mellitus over a two-year period. ADA.(2005).
Winter W.d., Cascading Disease Progression Analysis in Type 2 Diabetes: Integrating multiple biomarkers into single mechanism-based model. PharmSciFair.(2005).
Post T.M., Winter W.d., Jongh J.d., Moules I., Urquhart R., Eckland D. and Danhof M., Treatment Efficacy of Combination-Therapy based on a Mechanistic Characterisation of Disease Processes in Type 2 Diabetes Mellitus over a two-year period. Figon.(2005).
Winter W.d., Post T., Jongh J.d., Urquhardt R., Moules I., Eckland D. and Danhof M.A., Mechanistic Disease Progression Model for Type 2 Diabetes Mellitus and Pioglitazone Treatment Effects. PAGE.(2004). [Link to publication]
Ploeger B., Houwing N., Bom A., Zollinger D. and Danhof M., Reversal of rocuronium-induced neuromuscular block by cyclodextin ORG 25969: model development and validation. PAGE.(2004). [Link to publication]
Ruigt G.S., Ploeger B., Danhof M., Bom A., Houwing N. and Iersel M.P.v., Development of a mechanism-based PK-PD model of the reversal of rocuronium-induced neuromuscular block by ORG25969. IARS.(2004). [Link to publication]